Please assess the completion status of the following clinical trial:

Trial Title: Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Over 18 years old~* Able to read, understand, and provide written, dated informed consent prior to screening. Participants will be deemed likely to comply with study protocol and communicate with study personnel about adverse events and other clinically important information.~* Currently diagnosed with Major Depressive Disorder (MDD) and/or in a current major depressive episode, according to the criteria defined in the Diagnosis and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)~* Currently an inpatient at Stanford Hospital~* Meet the threshold on the total HAMD17 score of \>/=20 at screening/baseline.~* Qualifies and has access to outpatient rTMS treatment~Exclusion Criteria:~* Any structural lesion e.g. structural neurological condition, more subcortical lesions than would be expected for age, stroke effecting stimulated area or connected areas or any other clinically significant abnormality that might affect safety, study participation, or confound interpretation of study results.~* Metal implant in brain (e.g. deep brain stimulation), cardiac pacemaker, or cochlear~* History of epilepsy/ seizures (including history of withdrawal/ provoked seizures)~* Shrapnel or any ferromagnetic item in the head~* Pregnancy~* Autism Spectrum disorder~* Active substance use (\<1 week) or intoxication verified by toxicology screen--of cocaine, amphetamines, benzodiazepines~* Any current or past history of any physical condition which in the investigator's opinion might put the subject at risk or interfere with study results interpretation~* Cognitive impairment (including dementia)~* Current severe insomnia (must sleep a minimum of 4 hours the night before stimulation)~* Current mania~* Current unmanageable psychosis~* IQ \<70~* Showing symptoms of withdrawal from alcohol or benzodiazepines~* Parkinsonism or other movement d/o determined by PI to interfere with treatment~* More subcortical lesions than would be expected for age or a stroke effecting stimulated area or connected areas.~* Any other indication the PI feels would comprise data.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Dorsolateral Prefrontal Cortex (Type: EXPERIMENTAL): The accelerated theta burst stimulation protocol will be applied to the left dorsolateral prefrontal cortex (L-DLPFC), for 10 sessions per day for up to 5 days.
- Anterior Cingulate Cortex (Type: EXPERIMENTAL): The accelerated theta burst stimulation protocol will be applied to the left anterior cingulate cortex (ACC), for 10 sessions per day for up to 5 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).